138 related articles for article (PubMed ID: 36828005)
1. Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)-A Systematic Review.
Lundbech M; Damsbo M; Krag AE; Hvas AM
Semin Thromb Hemost; 2024 Apr; 50(3):474-488. PubMed ID: 36828005
[TBL] [Abstract][Full Text] [Related]
2. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis.
Falcón Araña L; Fuentes-García D; Roca Calvo MJ; Hernández-Palazón J; Gil Martínez J; Cascales Campos PA; Acosta Villegas FJ; Parrilla Paricio P
Cir Esp; 2015 Oct; 93(8):496-501. PubMed ID: 25882334
[TBL] [Abstract][Full Text] [Related]
3. Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Dranichnikov P; Mahteme H; Cashin PH; Graf W
Ann Surg Oncol; 2021 Nov; 28(12):7772-7782. PubMed ID: 33839978
[TBL] [Abstract][Full Text] [Related]
4. Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option.
Korakianitis O; Daskalou T; Alevizos L; Stamou K; Mavroudis C; Iatrou C; Vogiatzaki T; Eleftheriadis S; Tentes AA
Int J Hyperthermia; 2015; 31(8):857-62. PubMed ID: 26446799
[TBL] [Abstract][Full Text] [Related]
5. Coagulation after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort analysis.
Hurdle H; Bishop G; Walker A; Moazeni A; Paloucci EO; Temple W; Mack L; Shing M
Can J Anaesth; 2017 Nov; 64(11):1144-1152. PubMed ID: 28853010
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - A prospective cohort study.
Van Poucke S; Huskens D; Van der Speeten K; Roest M; Lauwereins B; Zheng MH; Dehaene S; Penders J; Marcus A; Lancé M
PLoS One; 2018; 13(6):e0193657. PubMed ID: 29927924
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.
Li J; Wang AR; Chen XD; Zhang YX; Pan H; Li SQ
World J Surg Oncol; 2022 Jun; 20(1):200. PubMed ID: 35701802
[TBL] [Abstract][Full Text] [Related]
8. Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.
Lim MC; Chang SJ; Park B; Yoo HJ; Yoo CW; Nam BH; Park SY;
JAMA Surg; 2022 May; 157(5):374-383. PubMed ID: 35262624
[TBL] [Abstract][Full Text] [Related]
9. Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis.
Wang Y; Ren F; Chen P; Liu S; Song Z; Ma X
Eur J Surg Oncol; 2019 Mar; 45(3):301-309. PubMed ID: 30786961
[TBL] [Abstract][Full Text] [Related]
10. Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.
Lundbech M; Krag AE; Iversen LH; Hvas AM
Int J Colorectal Dis; 2022 Jan; 37(1):17-33. PubMed ID: 34626208
[TBL] [Abstract][Full Text] [Related]
11. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review.
Gearing PF; Hawke JA; Mohan H; Heriot AG; Khan A; Beaumont A; Laing E; Waters PS
Eur J Surg Oncol; 2023 May; 49(5):902-917. PubMed ID: 36872111
[TBL] [Abstract][Full Text] [Related]
12. Epidural analgesia? A prospective analysis of perioperative coagulation in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Teoh DA; Hutton MJH; Else S; Walker A; Lee A; Mack LA
Am J Surg; 2019 May; 217(5):887-892. PubMed ID: 30808507
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study.
Tuovila M; Erkinaro T; Takala H; Savolainen ER; Laurila P; Ohtonen P; Ala-Kokko T
Int J Hyperthermia; 2020; 37(1):293-300. PubMed ID: 32208777
[No Abstract] [Full Text] [Related]
14. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
15. HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.
Sommariva A; Tonello M; Migliori E; Pizzolato E; Cenzi C; Mirabella M; Pilati P
Updates Surg; 2022 Oct; 74(5):1715-1723. PubMed ID: 35932406
[TBL] [Abstract][Full Text] [Related]
16. Survival and complications of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients: a systematic review and meta-analysis.
Tao J; Ji PT; Shen JJ; Lu Y
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5330-5348. PubMed ID: 34533809
[TBL] [Abstract][Full Text] [Related]
17. Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Sun BJ; Yue TM; Xu N; Fowler C; Lee B
Ann Surg Oncol; 2023 Dec; 30(13):8156-8165. PubMed ID: 37684372
[TBL] [Abstract][Full Text] [Related]
18. The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Ortega J; Orfanelli T; Levine E; Konstantinidis IT
Chin Clin Oncol; 2023 Apr; 12(2):16. PubMed ID: 36946185
[TBL] [Abstract][Full Text] [Related]
19. Morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases with or without early postoperative intraperitoneal chemotherapy: A propensity score matched study.
Dranichnikov P; Graf W; Cashin PH
Eur J Surg Oncol; 2022 Jul; 48(7):1598-1605. PubMed ID: 35177313
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.
Xia Y; Wang H; Zhang J; Wang Y
Int J Hyperthermia; 2023; 40(1):2165729. PubMed ID: 36775583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
